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Abstract
Background: Longicin is a defensin-like peptide, identified from the midgut epithelium of hard tick Haemaphysalis
longicornis. Several studies have already shown the antimicrobial and parasiticidal activities of longicin peptide and
one of its synthetic partial analogs, longicin P4. In this study, longicin peptides were tested for potential antiviral
activity against Langat virus (LGTV), a tick-borne flavivirus.
Methods: Longicin P1 and P4 peptides were chemically synthesized. Antiviral activity of the longicin peptides
against LGTV was evaluated through in vitro virucidal assays, wherein the antiviral efficacy was determined by
reduction in number of viral foci and virus yield. Additionally, longicin P4 was also tested for its activity against
human adenovirus, a non-enveloped virus. Lastly, to assess the importance of longicin on the innate antiviral
immunity of H. longicornis ticks, gene silencing through RNAi was performed.
Results: Longicin P4 produced significant viral foci reduction and lower virus yield against LGTV, while longicin
P1 failed to demonstrate the same results. Conversely, both longicin partial analogs (P1 and P4) did not show
significant antiviral activity when tested on adenovirus. In addition, longicin-silenced ticks showed significantly higher virus
titer after 7 days post-infection but a significantly lower titer was detected after an additional 14 days of observation as
compared to the Luc dsRNA-injected ticks. Mortality in both groups did not show any significant difference.
Conclusion: Our results suggest that longicin P4 has in vitro antiviral activity against LGTV but not against a
non-enveloped virus such as adenovirus. Likewise, though most cationic antimicrobial peptides like longicin
act directly on target membranes, the exact mechanism of membrane targeting of longicin P4 in enveloped
viruses, such as LGTV, requires further investigation. Lastly, while the in vitro virucidal capacity of longicin P4
was confirmed in this study, the role of the endogenous tick longicin in the antiviral defense of H. longicornis
against LGTV still remains to be demonstrated.
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Background
Ticks are hematophagous arachnids capable of transmit-
ting several disease-causing pathogens in domestic and
wild animals, including humans [1, 2]. As carriers of
several pathogenic microorganisms, protozoa, rickettsiae,
spirochaetes, and viruses [3, 4], ticks need to employ
broad spectrum innate immunity mechanisms that will
allow them to maintain the pathogens and commensal
microbes without impairing their viability and further
development [2, 5]. As previously demonstrated, anti-
microbial proteins and peptides play a major role in pro-
tecting ticks against microorganisms [6, 7].
Antimicrobial peptides are ancient immune molecules
that are important in invertebrate and vertebrate host
defenses [8, 9]. These peptides display broad-spectrum
biological activity against bacteria, yeast, fungi, proto-
zoan parasites and enveloped viruses [10–12] and have
been demonstrated to possess immunomodulatory prop-
erties [13]. Numerous small molecules such as defensins,
lysozymes or by tick-specific antimicrobial compounds
such as microplusin provide the direct antimicrobial
defense in ticks [2].
Longicin, a defensin-like peptide identified from the
midgut epithelium in the hard tick Haemaphysalis longi-
cornis, is a promising cationic antimicrobial peptide.
Many studies have shown that longicin and one of its
synthetic partial analogs (longicin P4) have antimicro-
bial, fungicidal, and parasiticidal properties [5, 14, 15].
Thus, making them attractive molecules to be used as
therapeutic agents, not only against tick-borne patho-
gens, but also to important human and animal disease-
causing agents. On the other hand, interest in the thera-
peutic applications of antimicrobial peptides or their
synthetic analogues is increasing due to the rise in resist-
ance to commonly used antibiotics [4, 16].
Tick-borne flaviviruses (TBFVs) cause considerable
disease and death worldwide, wherein infections are charac-
terized by mild to severe neurological symptoms, such as
meningitis and encephalitis [17, 18]. For Europe, Russia
and up to the eastern coast of Japan, tick-borne encephalitis
virus is considered as one of the most medically important
arboviruses with 10,000 to 15,000 cases recorded each year
[18, 19]. Since most TBFVs require at least a biosafety level
3 (BSL3) containment facility, the use of the naturally atten-
uated Langat virus (LGTV) provides a convenient BSL2
model of tick-borne encephalitis virus (TBEV) and other
highly pathogenic TBFVs [17]. In this study, we investigated
the virucidal activity of longicin P4 against LGTV, a mem-
ber of TBEV serocomplex of the Flaviviridae family.
Methods
Cell culture and virus
Baby hamster kidney (BHK-21) cells (ATCC CCL-100)
were maintained in Eagle’s minimum essential medium
(EMEM) (Wako, Japan) containing 10 % fetal bovine
serum (FBS) (Equitech, USA) and 1 % antibiotic/anti-
mycotic (Nacalai Tesque, Japan), while HeLa cells
(ATCC CCL-2) were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) (Nissui Pharmaceutical Co.,
Japan) supplemented with 10 % FBS, 1 % antibiotic/anti-
mycotic and 1 % L-glutamine (Wako, Japan). Both cells
were maintained at 37 °C under 5 % CO2 until use.
The LGTV TP21 used in this study was amplified in
BHK cells and the virus stock titer was determined by
focus forming assay as previously described [20] with
some modifications. Briefly, serial 10-fold dilutions of
the virus stock were plated on 1 × 105 cells/well of BHK-
21 cells in 24-well plates. The infected cells were
overlaid with 1.5 % methylcellulose containing modi-
fied Eagle’s medium (MEM) (Gibco, USA) with 1 %
FBS and 1 % antibiotic/anti-mycotic. Viral foci were
detected by a primary antibody against Langat virus
surface proteins (hyper immune mouse polyclonal
IgG) followed by Alexa Fluor® 488 goat anti-mouse
IgG (Invitrogen, USA), 3-4 days post-infection (dpi).
The number of foci was counted using a fluorescence
microscope and the titer of virus stock was expressed
as Foci-Forming-Unit (FFU). The virus stock was then
aliquoted and stored at -80 °C.
Human adenovirus 25 (ATCC VR-1103) was propagated
in HeLa cells and the virus stock titer was quantitated by
a 50 % tissue culture infectious dose (TCID50) assay as
previously described [21] with some modifications. Briefly,
serial 10-fold dilutions of the virus stock were plated
(eight wells per dilution) on 1 × 104 cells/well of HeLa
cells in 96-well plates. Cytopathic effect was scored 6-7
dpi. The TCID50 was calculated as the inverse of the dilu-
tion at which 50 % of the wells showed cytopathic effect,
calculated by the method of Reed & Muench [22].
Ethical approval
The use of the animals in our experiments was in ac-
cordance with the approved guidelines from Animal
Care and Use Committee of Kagoshima University
(approval number VM 13007).
Ticks and animals
Adult parthenogenetic (Okayama strain) H. longicornis
ticks were used in this study. These ticks were main-
tained for several generations by feeding on the ears of
Japanese white rabbits (Kyudo, Kumamoto, Japan) at the
Laboratory of Infectious Diseases, Joint Faculty of
Veterinary Medicine, Kagoshima University, Kagoshima,
Japan. The rabbits were solely used for tick feeding and
were not infected with any virus at any point during the
conduct of this study.
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Peptides
Peptides were synthesized using a Perkin-Elmer Applied
Biosystems 431 A Synthesizer with prederivatized poly-
ethylene glycol polystyrene arginine resin (Sigma Genosys,
Ishikari, Japan) and double coupling for residues. The
reduced peptides were purified using reverse HPLC.
The partial peptides are as follows: longicin P1
(QDDESDVPHVRVRRG 15 mer, Mw: 1764.8, pI: 5.43)
and longicin P4 (SIGRRGGYCAGIIKQTCTCYR 21 mer,
Mw: 2306.7, pI: 9.50). Peptide purity and integrity were
assessed by MALDI-TOF Mass. The peptides were dis-
solved in normal saline (0.85 % w/v of NaCl) with a final
concentration of 1 mmol/ml. The solutions were
stored at -30 °C until use [15].
Cell proliferation assay
The CellTiter 96® Non-Radioactive Cell Proliferation
Assay System (Promega, USA) was used to examine the
toxicity of longicin P1 and P4 peptides on BHK-21 cells
as per manufacturer’s instructions. In brief, BHK-21 cells
grown in EMEM were harvested and resuspended in a
fresh medium at a final concentration of 1 × 105 cells/ml.
Fifty microliters of the cell suspension was dispensed into
each well of a 96-well microtiter plate containing an equal
volume of either the 2-fold serially diluted longicin P1 and
P4 peptides or only the growth medium. After 72 h of
incubation, dye solution was added to each well followed
by 4 h of additional incubation. The reaction was then
stopped by adding a solubilization solution, and absorb-
ance was recorded at 570 nm in a microplate reader.
Cytotoxicity was expressed as the percentage inhibition of
cell growth (%) and was calculated as follows: Percentage
cell growth inhibition (%) = (1–A/B) × 100, where A and B
represent the absorbance value in the presence or absence
of the peptide [14].
Focus formation unit reduction assay
Antiviral activity of longicin peptides was determined by
measuring the reduction in the number of viral foci.
Briefly, BHK-21 cells were prepared in 24-well plates
(1 × 105 cells/ml). The infected cells were overlaid with
1.5 % methylcellulose containing MEM with 1 % FBS.
Viral foci were detected by a primary antibody against
Langat virus surface proteins (mouse polyclonal IgG)
followed by a secondary antibody (Alexa Fluor® 488 goat
anti-mouse IgG), three to four dpi. The number of foci
was counted using a fluorescence microscope and the
titer of virus was expressed as foci-forming-unit (FFU).
The baseline for medium-treated infected cells was the
mean of the viral foci number ± SD. Then the percentage
of foci reduction (RF%) compared to medium-treated
cells was calculated as follows: RF(%) = (C-T) × 100/C.
Where, C is the mean of the number of foci in medium-
treated wells (without peptide) and T is the mean of the
number of foci in peptide-treated wells [23].
Virucidal assay
Extracellular anti-LGTV activity of longicin P1 and P4
peptides was investigated by incubating 0.01 multiplicity
of infection (MOI) of LGTV suspension with 1.25 μM
longicin P1 or P4 for 2 h at 37 °C. For each assay, an
EMEM-treated LGVT and an EMEM only control culture
were included. Then, BHK-21 cells in 24-well plates were
infected with the treated viral suspension for 1 h at 37 °C.
Cells were washed with PBS to remove the unadsorbed vi-
ruses. Then, the plates were incubated at 37 °C for 3-4
days. Antiviral activity was determined by the reduction in
number of viral foci [23]. For the dose-dependent viru-
cidal assay, LGTV was treated with two-fold dilutions of
longicin P4 starting from 0.16 to 2.5 μM for 2 h at 37 °C.
On the other hand, to determine the time-dependent
effect of longicin P4, LGTV was treated with 1.25 μM at
different exposure times (0, 15, 30, 60, 120, 240 mins) at
37 °C. Foci forming unit reduction assay was used to
determine the dose- and time-dependent antiviral effects
of longicin P4 peptides.
The virucidal activity of longicin P4 was also tested
against a non-enveloped virus by incubating 10 TCID50
of adenovirus suspension with 1.25 μM of longicin P1 or
P4 for 2 h at 37 °C. For this assay, a DMEM-treated
LGVT and a DMEM only control culture were included.
Then, HeLa cells in 24-well plates were infected with the
treated viral suspension for 1 h at 37 °C. Cells were
washed with PBS to remove the unadsorbed viruses. The
microplate was then incubated at 37 °C and observed
daily under inverted microscope until CPE was more
than 50 % in the virus group. Images were taken 6-7
days post-infection and at same time, respective super-
natants were collected for titration.
Prophylactic antiviral assay
The prophylactic antiviral assay was performed by treating
BHK-21 cells in 24-well plates with EMEM or 1.25 μM of
longicin P1 or P4 for 2 h at 37 °C prior to virus infection.
After washing with PBS, cells were infected with 0.01
MOI of LGTV for 1 h for virus adsorption. Then cells
were washed by PBS and overlaid with 1.5 % methylcellu-
lose containing MEM with 1 % FBS. After 3-4 dpi, the
antiviral activity was determined by foci reduction as
described above [23].
Post-adsorption antiviral assay
The antiviral activity of longicin peptides against intra-
cellular replication of LGTV was performed by treating
BHK-21 cells in 24-well plates with EMEM or 1.25 μM
of longicin P1 or P4 after virus adsorption of 0.01 MOI
of LGTV for 1 h at 37 °C. Unadsorbed viruses were
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washed with PBS and then the cells were treated with
medium or 1.25 μM of peptides for 3-4 days. Antiviral
activity was determined by viral foci reduction assay as
described above [23].
Virus yield reduction assay
Briefly, BHK-21 cells in 24-well plates were infected at a
MOI of 0.01 with the LGTV pre-treated with longicin
P1, P4 or medium for 2 h at 37 °C. After 1 h of viral
adsorption at 37 °C, cells were washed with PBS to re-
move the unadsorbed viruses and consequently replaced
with EMEM with 1 % FBS. Three days post-infection,
supernatant from the infected cells were collected for
titration [24].
For the adenovirus virucidal assay, virus yield was
quantitated by a 50 % tissue culture infectious dose
(TCID50) assay. Briefly, HeLa cells infected with adeno-
virus, which were previously treated with longicin P1, P4
and medium were sampled at 7 dpi. Supernatants were
harvested and centrifuged to remove debris. Serial 10-fold
dilutions of the supernatants were plated (five wells per di-
lution) on 1 × 104 cells/well of HeLa cells in 96-well plates.
Cytopathic effect was scored 6-7 days post-infection. The
TCID50 was calculated as the inverse of the dilution at
which 50 % of the wells showed cytopathic effect, calcu-
lated by the method of Reed and Muench [22].
RNA interference (RNAi) and subsequent virus challenge
The PCR primers used for the synthesis of double-
stranded RNA (dsRNA) are listed in Table 1. The longicin
fragments were amplified by PCR from cDNA clones using
oligonucleotides including T7-forward and T7-reverse
primers to attach the T7 promoter recognition sites on
both the forward and reverse ends. The firefly luciferase
(Luc) was amplified from a vector DNA of pGEM-luc (Pro-
mega, Madison, WI, USA) through PCR using oligonucleo-
tides containing T7-forward and T7-reverse primers. PCR
products were purified using the GENECLEAN II kit (MP
Biomedicals, Ohio, USA). The T7 RiboMAX Express RNA
System (Promega) was used to synthesize dsRNA by
in vitro transcription following the manufacturer’s proto-
col. Successful construction of dsRNA was confirmed by
running 0.5 μl of the dsRNA products in a 1.5 % agarose
gel in a TAE buffer. Microinjection of dsRNA was per-
formed as previously described [25]. Briefly, 1 μg of longi-
cin dsRNA in 0.5 μl of distilled water was injected into the
hemocoel of unfed adult female ticks through the fourth
coxae, while Luc dsRNA was injected in the control group.
A total of 92 ticks per group were injected. After injection,
the ticks were held for 18 h in a 25 °C incubator to check
for mortality resulting from possible injury during injec-
tion. To initially confirm gene-specific silencing, 3 ticks
from each group were collected at 0 and 4 days after injec-
tion (dai), and then total RNA was prepared for RT-PCR.
RNA extraction was performed as previously described
[25] and PCR was carried out using longicin and actin
gene-specific primers (Table 2). PCR products were sub-
jected to electrophoresis in 1.5 % agarose gel in a TAE buf-
fer, and bands were visualized after staining the gel with
ethidium bromide using Quantity One 1-D Analysis Soft-
ware (Quantity One Version 4.5, Bio-Rad Laboratories,
Milan, Italy). Positive confirmation of longicin silencing
was monitored until 60 dai of longicin dsRNA.
To further check the longicin gene silencing efficiency,
expression analysis of the longicin mRNA was also per-
formed through real-time PCR using THUNDERBIRD™
SYBR® qPCR Mix (TOYOBO) with a 7300 real-time
PCR system (Applied Biosystems), as previously de-
scribed [26]. Briefly, gene-specific primers were designed
to target the H. longicornis longicin and ribosomal pro-
tein L23 (internal control) genes, as shown in Table 3.
Four-fold serial dilutions of cDNA of adult ticks were
used to generate standard curves. The real-time PCR
conditions were as follows: 95 °C for 10 min, 40 cycles
of a denaturation step at 95 °C for 15 s, and an an-
nealing/extension step at 60 °C for 60 s. The amount
of longicin expressions was divided by the amount of
L23 expressions for both respective groups to obtain
the normalized longicin expressions. Each sample was
run in triplicates and the data were analyzed using
the 7300 system SDS software (Applied Biosystems).
The percentage of gene silencing efficiency (%) of ticks
injected with longicin dsRNA compared to Luc dsRNA-
injected ticks was calculated as follows: Gene silencing
efficiency (%) = (1–LLong/LLuc) × 100. Where, LLong and
LLuc represent the normalized longicin expressions of
Table 1 List of PCR primers used for the synthesis of
double-stranded RNA
Primer name Primer sequence
Longicin RNAi forward CCTCATCTTCGTCCTTGTAG
Longicin RNAi reverse ATTATGACGACACACATAAT
Longicin T7 forward GGATCCTAATACGACTCACTAT
AGGCCTCATCTTCGTCCTTGTAG
Longicin T7 reverse GGATCCTAATACGACTCACTATA
GGATTATGACGACACACATAAT
Luc T7 forward GTAATACGACTCACTATAGGG
CTTCCATCTTCCAGGGATACG
Luc T7 reverse GTAATACGACTCACTATAGGC
GTCCACAAACACAACTCCTCC
Table 2 List of PCR primers used for the detection of longicin gene
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longicin dsRNA-injected and Luc dsRNA-injected ticks,
respectively [27].
Lastly, at 4 dai of longicin dsRNA, both longicin gene-si-
lenced and Luc gene-injected ticks were challenged with
LGTV (approximately 2.9 × 104ffu/0.5 μl) via percoxal
microinjection. Right after the challenge, the ticks were
held for 18 h in a 25 °C incubator to check for mortality
resulting from possible injury during injection. Thirty
ticks per group were monitored for tick mortality for up
to 35 dpi, while the remaining ticks per group were used
for virus titration done at 0, 1, 3, 7, 14, 21, 28 dpi.
Statistical analysis
Data were statistically analyzed using Student’s t–test
wherein P values less than 0.05 were regarded as signifi-
cant. All samples were tested at least in triplicate.
The Mantel-Cox log-rank test was also performed
using GraphPad Prism software to determine significant
difference in mortality (P <0.05) between control and
longicin gene-silenced ticks challenged with LGTV.
Results
Cytotoxicity activity of the longicin P4 peptide
To eliminate the possibility that foci reduction was due to
reduction in the number of viable host cells, we examined
the cell growth inhibitory effect of partial peptides longi-
cin P1 and P4 on BHK-21 cells (Fig. 1). Longicin P1 did
not show any significant cytotoxicity on BHK-21 cells. In
contrast, longicin P4 only demonstrated a non-significant
cytotoxic effect at 1.25 μM concentration. Based on these
results, the 1.25 μM concentration was used for both pep-
tides in the succeeding tests.
Antiviral effect of longicin P4 peptide against LGTV
Since defensin molecules accumulate in microbial mem-
branes resulting in formation of pores in the targeted
membrane, we checked first the extracellular virucidal ac-
tivity of longicin peptides against LGTV. As shown in
Fig. 2a, co-incubation of 1.25 μM longicin P4 with the
virus at 37 °C for 2 h reduced the number of fluorescence-
positive viral foci which is equivalent to a 70 % foci reduc-
tion (Fig. 2b). However, the same effect was not observed
from longicin P1 treatment.
Likewise, to further support that longicin P4 has a
virucidal activity against LGTV, we further checked if
the longicin P4 can lower down the virus yield post-
infection as compared to medium- and longicin P1-
treated LGTV. As shown in Fig. 2c, cells infected with
virus treated with longicin P4 produced almost two-fold
lower titer as compared to cells infected with either
medium- or longicin P1-treated virus. Although the
difference may seem low, the virus titer of longicin P4
group corresponds to more than 90 % foci reduction in
contrast to medium or longicin P1 treatment.
In addition, to further support that the possible mech-
anism of action of longicin P4 against LGTV is through
extracellular virucidal activity and exclude alternative
possibilities, we also conducted prophylactic and post-
adsorption antiviral assays. In the prophylactic antiviral
assay, cells exposed to longicin P1 and P4 for two hours
at 37 °C prior to virus infection showed statistically non-
significant foci reduction at 0.76 and -1.820 %, respect-
ively (Fig. 3a). Similarly, no significant antiviral activity
was also recorded for both longicin peptides against
LGTV in the post-adsorption antiviral assay, wherein,
longicin P1 and P4 showed 0.71 and 4.4 % foci reduc-
tion, respectively (Fig. 3b).
Moreover, after establishing that co-incubation of longi-
cin P4 with LGTV can successfully reduce foci formation
and virus yield, we then checked the dose-dependent and
time-dependent virucidal capacity of longicin P4. As shown
in Fig. 4a, 1.25 μM of longicin P4 can significantly produce
more than 50 % foci reduction against LGTV, while the
lowest concentration to show a significant foci reduction
was 0.65 μM. Likewise in Fig. 4b, we can also observe that
before adding to the cells, at least 30 min of close contact
between the virus and longicin P4 at 37 °C is required to
achieve significant foci reduction and the optimum viru-
cidal activity can be achieved at 2 h treatment.
Table 3 List of real-time PCR primers used for the determination
of longicin gene silencing efficiency
Primer name Primer sequence
Longicin real-time forward ACATGAAGGTCCTGGCTGTTG
Longicin real-time reverse TCTCGTCATCTTGAGCTGCTG
L23 real-time forward CACACTCGTGTTCATCGTCC
L23 real-time reverse ATGAGTGTGTTCACGTTGGC
Fig. 1 Cytotoxicity of longicin P1 and P4 against BHK-21 cells. MTT
assay was used to evaluate the cytotoxicity of the peptides. Values
are representative of triplicate samples and error bars indicate the
range of values obtained. *p < 0.05, longicin P1 vs longicin P4
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Antiviral effect of longicin P4 peptide against human
adenovirus
Our results showed that longicin P4 has a virucidal activ-
ity against LGTV and it is supported by previous findings
that suggest that cationic antimicrobial peptides such as
longicin P4 can only target pathogens possessing a mem-
brane [10, 11]. Thus, to check if longicin P4 can only exert
antiviral activity against membrane-bound or enveloped
viruses, we determined its virucidal activity against a non-
enveloped virus. As shown in Fig. 5a, co-incubation of
1.25 μM of longicin P4 and P1 failed to reduce adenovirus
infectivity leading to a successful viral infection and
marked cell death. In addition, no significant difference
can be observed in the virus yield from medium-, P1- and
P4-treated adenovirus (Fig. 5b).
Effect of longicin gene silencing in LGTV replication in
adult H. longicornis
To evaluate the importance of longicin in the innate
immunity of H. longicornis adult ticks against LGTV,
a b
c
Fig. 2 Virucidal effect of longicin P1 and P4 against Langat virus. a Fluorescence images of BHK-21 cells infected with Langat virus (TP-21) treated
with medium only, 1.25 μM of P1 and P4 for 2 h at 37 °C. Arrowheads point to positive fluorescence FFU. b Foci reduction and c yield reduction
assays were used to determine extracellular virucidal effect of longicin peptides. The percentage of foci reduction (%) was obtained by comparing
against medium-treated cells maintained in parallel. All experiments were conducted in triplicates and error bars indicate the range of values. NC
refers to cells with no treatment and no infection. *p < 0.05, longicin P4 vs longicin P1 or medium
a b
Fig. 3 Prophylactic (a) and post-adsorption (b) antiviral effects of
longicin P1 and P4 against Langat virus. Experiments were conducted in
triplicates and error bars indicate the range of values. The percentage of
foci reduction (%) was obtained by comparing against medium-treated
cells maintained in parallel. *p < 0.05, longicin P4 vs longicin P1
or medium
a b
Fig. 4 Dose-dependent (a) and time-dependent (b) virucidal effects
of longicin P4 against Langat virus. Experiments were conducted in
triplicates and error bars indicate the range of values. The percentage
of foci reduction (%) was obtained by comparing against medium-
treated cells maintained in parallel. *p < 0.05, as compared to the
lowest concentration or to 0 min
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gene silencing through RNAi was performed. Ticks
were individually injected with either longicin dsRNA
or with Luc dsRNA for the control group. Silencing
of longicin gene was confirmed visually by regular
RT-PCR and gel electrophoresis (Fig. 6a). In addition,
gene silencing efficiency was also determined using
real-time PCR (Fig. 6b), wherein more than 90 % of
longicin mRNA reduction can be observed for at least
60 days after microinjection of longicin dsRNA.
Although mean virus titers from whole ticks (Fig. 6c)
demonstrate significant differences at 7 and 21 dpi
between longicin dsRNA and Luc dsRNA injected ticks,
the titers for both groups eventually equalized at the end
of the observation period. In addition, no significant
difference was observed in tick mortality on both groups
after 35 dpi (Fig. 6d).
Discussion
Several studies have already shown the antimicrobial,
fungicidal, and parasiticidal activities of longicin and one
of its synthetic partial analogs (longicin P4). A previous
study has shown that some known defensins have a
common motif (G3RRGG5) which could be related to
their antiparasitic activity [28]. Such motif was also
found in longicin P4 suggesting that this motif is the
one responsible for its antiparasitic activity [15, 29].
Since longicin P4 has been shown to possess antimicro-
bial, fungicidal, and parasiticidal properties, we decided
a b
Fig. 5 Virucidal activity of longicin P1 and P4 against adenovirus. a Images of HeLa cells infected with human adenovirus 25 treated with medium
only, 1.25 μM of longicin P1 and P4 for 2 h at 37 °C. Images were taken 7 dpi (200xmagnification). b TCID50 was used to determine the virus yield
titers of the collected supernatants of the treatment groups. Data expressed as means ± SD
a b
c d
Fig. 6 Effect of longicin silencing in tick mortality and virus titer. a To confirm gene-specific silencing, 3 ticks from each group were collected at 0,
4, 7, 14, 21, 28, 35, 42 and 60 dai of dsRNA. Initial confirmation of longicin silencing was carried out through RT-PCR and gel electrophoresis
(a), while gene silencing efficiency was determined by real-time PCR (b). Virus titers (c) and tick survival (d) were monitored after injecting
LGTV on 4-day luciferase dsRNA- or longicin dsRNA-inoculated ticks. Values for mortality (n = 30 ticks per group) were expressed as the percentage of
live ticks remaining to the number of ticks used at the beginning of the experiment in different time courses. Significant difference (*p < 0.05) was
determined using the Mantel-Cox log-rank test, while error bars in virus titers indicate SD in mean values of 5 ticks. *p < 0.05, luciferase vs longicin
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to test the peptide for its antiviral activity against a tick-
borne flavivirus.
In this study, our data show that co-incubation treat-
ment of LGTV with longicin P4 at 1.25 μM concentration
prior to infection resulted in significant foci reduction.
And to clarify if this antiviral activity is also present in the
full-length (FL) longicin peptide, we also checked the anti-
viral capacity of the FL longicin against LGTV. Initially,
we determined first the non-cytotoxic concentration of FL
longicin on BHK cells (see Additional file 1a) and used
this concentration as the treatment concentration. As
expected, FL longicin also exhibited an almost 40 % viral
foci reduction (see Additional file 1b).
On the other hand, the virus yield from cells infected
with virus co-incubated with longicin P4 produced lower
titer as compared to cells infected with either medium
or longicin P1 treated virus, resulting in more than 90 %
foci reduction as compared to medium or longicin P1
treatment.
The lower virus yield from cells infected with virus co-
incubated with longicin P4 further confirm that the viru-
cidal activity of longicin P4 is extracellular, through close
contact, as previously shown in another study that longi-
cin P4 impairs parasite membranes (Toxoplasma gondii)
resulting in the reduction of infection in cells [15]. In
addition, the failure of longicin P4 to significantly reduce
foci formation in the prophylactic and post-adsorption
antiviral assays clearly supports that the antiviral activity
of the peptide is exerted through extracellular inactiva-
tion of the virus particle.
LGTV, being an enveloped virus, has an outer coating
that is composed of a lipid bilayer. Viral envelope can be
a target for longicin as defensin molecules accumulate in
microbial membranes resulting in the formation of pores
in the targeted membrane [30]. However, additional
experiments to show the binding between extracellular
virus and longicin P4 are needed to fully establish the
exact mechanism of membrane targeting of longicin in
enveloped viruses. Nevertheless, to confirm that the
effect of longicin P4 may only be limited to membrane-
bound targets, a common trait for cationic antimicrobial
peptides, we tested its virucidal activity against human
adenovirus 25, a non-enveloped virus. As shown in Fig. 5,
longicin P4 failed to inhibit virus replication, thus sup-
porting the claims that although cationic antimicrobial
peptides have diverse targets, their activity is generally
limited to targets with membranes [11, 29].
However, previous findings by Smith and Nemerow
[31], showed that human α-defensin can inhibit adeno-
virus infection by directly binding to non-enveloped
adenoviral capsid, inhibiting virus disassembly. Such bind-
ing ultimately leads to inhibition of endosomal membrane
penetration during cell entry. This finding further explains
that the virucidal activity of longicin P4 may only be
limited to enveloped viruses and the synthetic peptide
does not target the capsid of adenovirus. Likewise, it is
also possible to suppose that longicin P4 can directly bind
on the membrane of LGTV without disrupting the viral
envelope, and in effect inhibits the binding of the virus to
cellular receptors for viral entry. However, this mechanism
remains to be elucidated.
Lastly, to fully elucidate the importance of longicin in
the innate immunity of H. longicornis ticks against LGTV,
gene silencing through RNAi was performed. After suc-
cessfully silencing the longicin gene, ticks were challenged
with LGTV via microinjection. Preliminary results on the
effect of longicin gene silencing on virus titer show that
significant difference can be observed at 7 and 21 dpi. At
7 dpi, longicin gene-silenced ticks produced higher viral
titer as compared to luc dsRNA injected ticks, which may
be attributed to longicin gene silencing. However, at 21
dpi, longicin gene-silenced ticks showed lower viral titer
as compared to the control. Although a relatively high
gene silencing efficiency (more than 90 %) can be ob-
served for at least 60 dai, the lower viral titer in the longi-
cin gene-silenced group at 21 dpi remains to be answered,
thus suggesting that the effect of longicin gene silencing
on the survival dynamics of LGTV in vivo still remains
unclear. In addition, a complete knockdown of the longi-
cin gene may also be needed to fully assess the function of
longicin against LGTV in vivo.
On the other hand, for the whole duration of the
study, no significant difference in mortality was observed
on both longicin gene-silenced and Luc dsRNA-injected
ticks. Failure to observe any significant effect on tick
mortality on the longicin-silenced ticks, may suggest that
the activity of longicin in the tick is not related to the
control LGTV infection or the virus model used for this
study may not be suitable to test our hypothesis. Likewise,
the sturdiness of ticks against any harmful effect due to
LGVT infection may be expected since ticks act as highly
efficient reservoirs of flaviviruses [32]. Moreover, the
failure of longicin silencing to affect the tick’s resistance to
LGTV suggests that the peptide’s activity may only be
effective in vitro. As previously observed, activities of anti-
microbial peptides can be undesirably affected by various
relevant factors present in vivo and these may include
proteases, polyanions and high mono- and divalent cation
concentrations [12].
Conclusion
In summary, we have successfully established the extra-
cellular virucidal activity of longicin P4 against LGTV
in vitro, and to our knowledge, this is the first report of
an antiviral activity of a native or synthetic antimicrobial
peptide derived from H. longicornis. However, the role of
the endogenous tick longicin in the antiviral defense of
H. longicornis still remains to be demonstrated.
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Additional file
Additional file 1: Virucidal effect of full-length (FL) longicin against
LGTV. Foci reduction assay was used to determine the extracellular
virucidal effect of baculovirus-expressed FL longicin peptide using 0.5 nm
concentration. Based from the cell proliferation assay (a), 0.5 nM of FL
longicin showed no significant cytotoxicity on BHK cells that may affect
the result of the foci reduction assay. (b) The percentage of foci reduction
(%) was obtained by comparing against medium-treated cells maintained
in parallel. All experiments were conducted in triplicates and error bars
indicate the range of values. (PDF 109 kb)
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